737
Views
7
CrossRef citations to date
0
Altmetric
Research paper

Feedback activation of GATA1/miR-885-5p/PLIN3 pathway decreases sunitinib sensitivity in clear cell renal cell carcinoma

, , , , , & show all
Pages 2195-2206 | Received 01 Mar 2020, Accepted 18 Jul 2020, Published online: 12 Aug 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Lei Shi, Mengheng Wang, Haiping Li & Pengtao You. (2021) MicroRNAs in Body Fluids: A More Promising Biomarker for Clear Cell Renal Cell Carcinoma. Cancer Management and Research 13, pages 7663-7675.
Read now

Articles from other publishers (4)

Masoumeh Eliyasi Dashtaki & Sorayya Ghasemi. (2023) Anti-angiogenic Drug Resistance: Roles and Targeting of Non-coding RNAs (microRNAs and long non-coding RNAs). Current Molecular Pharmacology 16:8.
Crossref
Yunxia Wang, Xiaolin Liu, Luyao Gong, Weihong Ding, Wenjing Hao, Yeheng Peng, Jun Zhang, Weimin Cai & Yuan Gao. (2023) Mechanisms of sunitinib resistance in renal cell carcinoma and associated opportunities for therapeutics. British Journal of Pharmacology 180:23, pages 2937-2955.
Crossref
Yiqi Liu, Hu Zhang, Yuan Fang, Dongshan Tang & Zhigang Luo. (2023) Non-coding RNAs in renal cell carcinoma: Implications for drug resistance. Biomedicine & Pharmacotherapy 164, pages 115001.
Crossref
Juan Jin, Yuhao Xie, Jin-Shi Zhang, Jing-Quan Wang, Shi-Jie Dai, Wen-fang He, Shou-Ye Li, Charles R. AshbyJr.Jr., Zhe-Sheng Chen & Qiang He. (2023) Sunitinib resistance in renal cell carcinoma: From molecular mechanisms to predictive biomarkers. Drug Resistance Updates 67, pages 100929.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.